Insider Trading History of Kalen Holmes

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Kalen Holmes since 2019. This trader's CIK number is 1476414. At the time of last reporting, Kalen Holmes was the Officer of 1life Healthcare Inc. (stock ticker symbol ONEM). Also see all insider trading activities at 1life Healthcare Inc.

Note that in the past Kalen Holmes also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at 1life Healthcare Inc (ONEM) by Kalen Holmes

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 ONEM 0 $0 0 $0 4,534 $0
2021 ONEM 0 $0 31,915 $1,315,663 0 $0

Yearly summary of insider trading at Zumiez Inc (ZUMZ) by Kalen Holmes

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 ZUMZ 0 $0 4,000 $181,320 0 $0
2021 ZUMZ 0 $0 4,967 $214,028 0 $0
2019 ZUMZ 0 $0 11,395 $395,292 0 $0


Insider trading activities at 2 companies by Kalen Holmes:

1. 1life Healthcare Inc (ONEM)

2. Zumiez Inc (ZUMZ)

Table 1. Insider trading of 1life Healthcare Inc (ONEM) by Kalen Holmes

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-06-02 ONEM Option Ex 4,534 .00 0
2021-01-12 ONEM Sale 31,915 41.22 1,315,663

Table 2. Insider trading of Zumiez Inc (ZUMZ) by Kalen Holmes

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-02-16 ZUMZ Sale 2,000 45.79 91,580
2022-01-11 ZUMZ Sale 2,000 44.87 89,740
2021-08-16 ZUMZ Sale 2,483 41.99 104,261
2021-07-15 ZUMZ Sale 2,484 44.19 109,767
2019-12-09 ZUMZ Sale 11,395 34.69 395,292

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kalen Holmes (Officer of 1life Healthcare Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.